ArticleThe pharmacogenomics journal2013

Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities in Asperger syndrome.

E Radulescu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.